Prognose

Kaufen	1
Halten	0
Verkaufen	0

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

SenesTech, Inc. (SNES) Q4 2024 Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Robert Blum – Lytham Partners Joel Fruendt – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Sameer Joshi – H.C. Wainwright Operator Good day, and welcome to the SenesTech Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call.» Mehr auf seekingalpha.com
SenesTech Announces Record Fourth Quarter and Full Year 2024 Financial Results with 70% Quarterly Revenue Growth; Gross Profit Margins of 61%; Reduction in Operating Expenses; and Dramatic Improvement in Adjusted EBITDA
Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX , March 12, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, today announced fourth quarter and full year 2024 financial results. Q4 2024 Highlights Revenue increased 70% to $501,000 in Q4 2024 compared to $295,000 in Q4 2023, led by growth in e-commerce which increased 206%.» Mehr auf prnewswire.com
SenesTech Announces Warrant Exercise for $1.1 Million in Gross Proceeds
PHOENIX , March 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in fertility control solutions for managing rodent populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 374,718 shares of the Company's common stock originally issued by the Company on August 23, 2024, each having an original exercise price of $4.35 per share, at a reduced exercise price of $2.90 per share. In addition, the Company will issue new short-term warrants, as described below.» Mehr auf prnewswire.com

Unternehmenszahlen

Im letzten Quartal hatte SenesTech Aktie einen Umsatz von 481,47k€ und ein Nettoeinkommen von −1,21 Mio€

(EUR)	Dez. 2024	YOY
Umsatz	+481,47k	80,42%
Bruttoeinkommen	+293,11k	151,18%
Nettoeinkommen	−1,21 Mio	23,07%
EBITDA	−1,16 Mio	24,48%

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+3,02 Mio€
Anzahl Aktien	1,75 Mio
52 Wochen-Hoch/Tief	+9,00€ - +1,73€
Dividenden	Nein
Beta	0,1
KGV (PE Ratio)	−0,65
KGWV (PEG Ratio)	−0,05
KBV (PB Ratio)	+1,59
KUV (PS Ratio)	+1,77

Unternehmensprofil

SenesTech, Inc. entwickelt eine Technologie zur Kontrolle von Tierschädlingspopulationen durch Fruchtbarkeitskontrolle. Es bietet ContraPest an, einen Flüssigköder, der die Fortpflanzung von männlichen und weiblichen Ratten einschränkt. Das Unternehmen wurde im Jahr 2004 gegründet und hat seinen Hauptsitz in Phoenix, Arizona.